title: Cholesterol oxides induce programmed cell death in microglial cells.
abstract: N9 microglial cells were used as a model to examine the effect of cholesterol oxides on central nervous system microglia. Results indicated that 25-OH-cholesterol was the most cytotoxic agent among the cholesterol oxides tested. During the process of cell death, this agent caused prominent nuclei condensation and significant DNA fragmentation, a phenomenon association with programmed cell death. Cholesterol oxides were able to potentiate the bacterial lipopolysaccharide (LPS)-induced nitric oxide production to various degrees. Consistent with this finding, Northern blot analysis indicated that 25-OH-cholesterol potentiated the LPS-induced nitric oxide synthase RNA levels. The cytotoxicity of 25-OH-cholesterol could be prevented by methyl-beta-cyclodextrin, a glucose polymer known to cause cholesterol oxide efflux from cells. While much attention has been focused on the cytotoxicity of cholesterol oxides on immune cells within the blood, including lymphocytes and macrophages, the results from this study indicated for the first time that these agents are toxic to microglial cells derived from the central nervous system.
authors.affiliation: Department of Anatomy, University of Arkansas for Medical Sciences, Little Rock 72205, USA.
authors.forename: J Y
authors.initials: JY
authors.lastname: Chang
authors.forename: J A
authors.initials: JA
authors.lastname: Chavis
authors.forename: L Z
authors.initials: LZ
authors.lastname: Liu
authors.forename: P D
authors.initials: PD
authors.lastname: Drew
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects*; D002460:Cell Line; D003505:Cyclodextrins / Q000494:pharmacology; D053938:DNA Fragmentation / Q000187:drug effects; D004357:Drug Synergism; D006888:Hydroxycholesterols / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000633:toxicity*; D008070:Lipopolysaccharides / Q000008:administration & dosage / Q000633:toxicity; D051379:Mice; D017628:Microglia / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009569:Nitric Oxide / Q000096:biosynthesis; D019001:Nitric Oxide Synthase / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D047392:beta-Cyclodextrins
chemical_list: D003505:Cyclodextrins; D006888:Hydroxycholesterols; D008070:Lipopolysaccharides; D012333:RNA, Messenger; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin; D009569:Nitric Oxide; C007997:25-hydroxycholesterol; D019001:Nitric Oxide Synthase